Juno Therapeutics Prices IPO Above Expected Range

MarketWatch Pulse

Juno Therapeutics Inc. priced its initial public offering above the expected range late Thursday. Juno said it will offer 11 million shares at $24 apiece. The expected range on the IPO was $21 to $23 a share. Juno is a biotech company that is developing cancer therapies. Shares will begin trading on the Nasdaq on Friday.

Copyright © 2014 MarketWatch, Inc.

Continue Reading Below